Bio-Rad Labs (BIO) Tops Q2 EPS by 32c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $285.94 -2.22%
EPS Growth %: -30.7%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -30.7%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.00, $0.32 better than the analyst estimate of $2.68. Revenue for the quarter came in at $681.1 million versus the consensus estimate of $697.96 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Sharon AI surges premarket; New Oriental gains, Medline slips
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
